CURE Pharmaceutical and CUREfilm featured on Drug Development & Delivery

The actual design and construction of an oral film capable of effective therapeutic delivery can be challenging and requires the creation of new technologies. As a result of these innovations, buccal films are now a commercially viable dosage form that can solve many problems faced by the pharmaceutical industry, patients, and their caregivers, according to CURE Pharmaceutical’s CEO Rob Davidson and its COO Jessica Rousset.

Oral films will be able to replace daily injections, such as apomorphine shots taken by patients suffering from Parkinson’s disease. They can improve the bioavailability of drugs, such as cannabinoids, potentially lowering their dose and psychoactive side effects. When rapid symptom relief is needed, they can deliver a bolus effect. They are a convenient alternative to unpalatable liquids for children and hard-to-swallow pills for the elderly.

“CURE Pharmaceutical’s approach to buccal film development with CUREfilm leverages the inevitable salivary flush of a single layer film to create better drug-release profiles,” said Davidson and Rousset. “We design our products to combine the fast onset bolus effect of buccal delivery with the extended release of GI delivery to achieve an overall pulsatileor sustained-release profile. Indeed, with buccal delivery, blood levels can peak quickly, and a shorter half-life can mean the effect wears off rapidly.”

Read the full article: BUCCAL FILMS – Better Drug Release & Patient Experiences With Buccal Films (Drug Development & Delivery)

 

October 3rd, 2018|Categories: Client News|Tags: , , , , |

CURE Pharmaceutical joins forces with Canopy Growth in exclusive partnership

CURE Pharmaceutical has signed a deal with Canopy Growth Corp (TSX:WEED, NYSE:CGC), where Canopy will have an exclusive license to CURE’s patented, multi-layer oral thin film technology for use with cannabis extracts and biosynthetic cannabinoids.

Jessica Rousset, COO for CURE Pharmaceutical, says the licence agreement allows CURE to accelerate and expand the impact of its technology by joining forces with Canopy, which has broad market access and resources to bring a product to market.

See coverage below:

CURE Pharmaceutical joins forces with Canopy Growth in exclusive partnership (Proactive Investors)
CURE Pharmaceutical Expands Distribution of  CUREfilm Technology With First Licensing Agreement (Drug Development and Delivery)
Canopy Growth Corp. Scores Huge Pharma Deal (Motley Fool)

September 12th, 2018|Categories: Client News|Tags: , , , , , |

Ventura County Star features Oxnard-based CURE Pharmaceutical

Interest in cannabis-based medicine is on the rise, and Oxnard-based CURE Pharmaceutical is positioning itself to become a key player in the burgeoning industry.

CURE Pharmaceutical, founded in 2011, might be small, but the company is carving a niche for itself in a county that has no shortage of biopharmaceutical businesses.

Read the full article: Oxnard’s CURE Pharmaceutical looks to grow its business through cannabis-based medicine (Ventura County Star)

August 9th, 2018|Categories: Client News|Tags: , , , |

CUREfilm redefines how medicines are delivered and experienced

The CUREfilm technology, developed by Cure Pharmaceutical, delivers drugs through a dissolvable strip that can be applied in the oral cavity or onto the skin. It replaces the need for swallowing or injecting medicines. The film has the ability to hold multiple active ingredients on one dissolvable strip, hence, eliminating the need to take multiple medications for daily treatments.

“CUREfilm products are designed to optimize drug release profiles and achieve a target product profile,” says Jessica Rousset, COO at CURE Pharmaceutical. “Unlike traditional oral drug delivery, CUREfilm can be designed to bypass the gastrointestinal (GI) tract, avoiding GI-related side effects and inactivation in the gut or liver.”

Rousset spoke to Pharmaceutical Technology about the advantages of CUREfilm and its applications in drug delivery.

Read the full article: An alternative to pills and injections: CUREfilm redefines how medicines are delivered and experienced (Pharmaceutical Technology)

June 8th, 2018|Categories: Client News|Tags: , , , , , |